Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Zhang, Yuan; Chen, Lei; Hu, Guoqing; Zhang, Ning; Zhu, Xiaodong; Yang, Kunyu; Jin, Feng; Shi, Mei; Chen, Yu‐Pei; Hu, Wei‐Han; Cheng, Zhibin; Wang, Siyang; Tian, Ye; Wang, Xicheng; Sun, Yan; Li, Jingao; Li, Wen‐Fei; Li, Yuhong; Tang, Ling‐Long; Mao, Yan‐Ping; Zhou, Guan‐Qun; Sun, Rui; Liu, Xu; Guo, Rui; Long, Guoxian; Liang, Shaoqiang; Li, Ling; Huang, Jing; Long, Jinhua; Zang, Jian; Liu, Qiaodan; Zou, Li; Su, Qiong-Fei; Zheng, Baomin; Xiao, Yun; Guo, Ying; Han, Fei; Mo, Hao‐Yuan; Lv, Jia‐Wei; Du, Xiaojing; Xu, Cheng; Liu, Na; Li, Ying‐Qin; L.K. Chua, Melvin; Xie, Fang‐Yun; Sun, Ying; Ma, Jun

doi:10.1056/nejmoa1905287

Public

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Published in New England Journal of Medicine • May 31, 2019

Authors:

Yuan Zhang

Lei Chen

Guoqing Hu

Abstract

BACKGROUND: Platinum-based concurrent chemoradiotherapy is the standard of care for patients with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine and cisplatin induction chemotherapy has shown promising efficacy in phase 2 trials. METHODS: In a parallel-group, multicenter, r...

Subject

Medicine

Gemcitabine

Induction chemotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!